Alexandria Forbes, MeiraGTx CEO (Hollie Adams/Bloomberg via Getty Images)
October 15, 2024 10:37 AM EDT
R&D
Cell/Gene Tx

MeiraGTx's stock ris­es on small Parkin­son's gene ther­a­py dataset

Max Gelman

Senior Editor

MeiraGTx un­veiled re­sults from a small dataset for its Parkin­son’s dis­ease gene ther­a­py on Tues­day morn­ing, caus­ing its shares $MGTX to jump by as much …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times